Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects - Test2 - elhamkhani - TriplyDB

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

http://www.wikidata.org/entity/Q28657600

about

Neuroinflammation and psychiatric illness So depression is an inflammatory disease, but where does the inflammation come from?A review of anti-inflammatory agents for symptoms of schizophrenia Acetylsalicylic acid (aspirin) for schizophrenia Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology Cytokines in Schizophrenia: Hope or Hype?Role of astrocytic glutamate transporter in alcohol use disorder Methodological Issues in Cytokine Measurement in Schizophrenia Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders The role of inflammation in schizophrenia Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates Understanding the role of P2X7 in affective disorders-are glial cells the major players?The neuroimmunology of schizophrenia The cytokine model of schizophrenia: emerging therapeutic strategies Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence Inflammation and schizophrenia Toxoplasma gondii-induced neuronal alterations Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications Dysfunction in the coagulation system and schizophrenia Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review A Preliminary Genetic Analysis of Complement 3 Gene and Schizophrenia Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosis Transcriptome sequencing of the choroid plexus in schizophrenia Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity Inflammation and the two-hit hypothesis of schizophrenia.Viral infection, inflammation and schizophrenia Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia.Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.In vivo imaging of neuroinflammation in schizophrenia The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Effects of the modified electric convulsive treatment (MECT) on cell factors of schizophrenia

P2860

Q21245244-3915980D-B0F7-4B42-83B9-9F96080A32AD Q21245291-B4A98282-22E2-4D05-A2CD-4E5A177B81B0 Q22241827-1E50FE4B-0985-4990-91A3-2E1FC1FA9A40 Q24186077-8F4FBA29-E285-40B6-A471-130D05B4BB98 Q24630651-439E678C-E3A4-40CF-8F1A-D8B915A5612A Q26741541-875473AB-8109-45CE-8155-2038737D365B Q26745684-97717664-E9C8-46CB-8C0D-BA14D282D329 Q26750430-354C35CD-294F-4E13-9792-48FDFBAEE467 Q26750910-36345408-5E0E-4144-B985-41E33FD10D77 Q26751839-2E3A1C0E-969E-4876-B1D1-7D9EFB012E8C Q26765419-37C969E5-9923-49E5-8F9C-08B1470CBE64 Q26779719-520A23A6-104F-4F44-8166-0A88C7416F6E Q26781620-578340EC-AC4F-4DC7-9EDB-395AB19AC3D6 Q26784904-B990164D-1222-42BB-8ADE-B79BAA79A98A Q26786354-F103BE3F-5825-4143-AE07-C51F3A3EFF3E Q26798961-D3C58A3D-B4C9-4E57-9857-B3C4E0E182DC Q26859392-57009E75-71AE-46EE-84FE-08674643CF1C Q26865996-3A6DCC0B-D6B9-405D-9F16-532106286D71 Q26999061-D10B525A-7BBA-4AC4-96BC-5F7C2A113D79 Q27002489-335F40A6-8557-47E7-96C9-7D5F36F3781C Q27027025-52C6BD62-3DAF-4532-9FA8-9C2491D8A99F Q28066646-662276A0-B16B-408B-8CB6-C784E9F547D7 Q28068412-AD168961-1C98-43CE-8A1B-D2B0DF6C881C Q28069770-ADE226FE-0A53-4479-B917-3995D8FEF9E0 Q28077391-3DC8E731-C7F9-4B95-9544-8E63B537098D Q28547464-9EA708A6-218D-4205-8819-11BA496FE9B1 Q29396093-F93E6051-8BEB-443A-9EAB-349A4AB8C96B Q30355368-8F19B0F8-2419-42AE-873B-60F39C7A3932 Q30355377-21CBAB9C-2AEF-4695-8F73-EF48272C1D44 Q30363952-B0082F2B-4289-4906-A1F7-09292EA7AC23 Q30392177-4A6C1197-D41B-4207-B357-EC39B962B000 Q30422062-E4AC361C-63A9-44E6-B9C8-28936F91C2F7 Q30440507-3B32761E-A097-4F0B-BCF4-8209135BA919 Q30442468-06D28FCA-8A22-48ED-B321-32C8FCA414F8 Q30442608-7D3461EC-86A2-4AB3-8672-7F3AB148E470 Q30447546-E0836541-BF1C-4C89-B3ED-042BADBF7119 Q30966978-8ECBBEF9-481C-4529-9D42-D6915F79AFB8 Q33451672-FA42607E-0C2C-4D1E-A7F1-B36CF4747F52 Q33453744-EB28E6F9-E8AA-4B91-8DD7-A9C96B7B5289 Q33598482-938125CE-7064-4E02-86DB-2954AC5D4481

P2860

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

http://www.wikidata.org/entity/Q28657600

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@ast

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@en

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@nl

type

label

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@ast

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@en

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@nl

prefLabel

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@ast

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@en

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@nl

P1433

Q28657600-9C8F590E-9E29-4821-9572-3EED63426841

P1476

Q28657600-B3347C7A-A5EF-4B2B-AB50-425C18E86FF4

P2093

Q28657600-4D62798D-98AB-4026-9240-EB20D0065B03

Q28657600-73E5D5B6-1FFA-4477-BA75-C10B004876E4

Q28657600-BEBF9C77-79E0-490A-89B7-4C0DB822E6F6

Q28657600-D5AA1785-5D86-4B9B-8D11-F5DBD5995AAC

P2860

Q28657600-0AF72EE3-3951-4714-80ED-7C6AF15936B5

Q28657600-14D057C7-C20E-4B1A-917D-3D6E7CE00253

Q28657600-151BCA36-39A9-4E93-A173-6BAFFB9AC5BA

Q28657600-16A5E78B-67C4-4744-861D-A6A256C99F5D

Q28657600-19EFE301-53B7-4AFA-98B1-D7C5428A7EF9

Q28657600-1C5ACC6E-FB67-41E6-BD6E-AC9B657AF566

Q28657600-1E071AF2-9CE4-498D-992F-F5F4349025F5

Q28657600-1EEDC606-BB77-4894-9CA9-BC08B9BC3A7F

Q28657600-1FB6E88C-82F9-435C-A4DF-56E0941AFAE4

Q28657600-20151A1A-6E5A-4F6F-8651-2309E3EA8ABC

P304

Q28657600-D556A7B9-8E15-42AD-A786-305384A18980

P31

Q28657600-7044A7FF-E24F-4CCA-B668-A342B8865A4C

Q28657600-74735FBF-9157-4CAF-97F3-7FA61F42853B

P3181

Q28657600-012C9988-9586-483A-B7B2-D77A0C4B8BDF

P356

Q28657600-7AB83D17-4107-42D7-B9CA-7D442915C162

P407

Q28657600-F5916C94-4C7E-4F23-8455-2D0CF42A54DF

P433

Q28657600-0648DE72-F322-455A-9882-0D8443EF1430

P478

Q28657600-8CD2B748-5C7F-411E-9D7E-D0BA4F43A963

P50

Q28657600-6cbfc2c7-4790-fe3e-af5c-d8239cdd0c21

P577

Q28657600-8DB7DF6F-3AFD-4695-AAC6-1B32CB880B92

P5875

Q28657600-FC9E5904-67F9-4CDD-9169-E7F78F8DC1E6

P698

Q28657600-DF8C573C-D495-4935-93F2-57B0CE695635

P921

Q28657600-489B2ABD-6C9F-4224-9EAC-4967BDF26505

Q28657600-C2F4223A-FAD0-43FA-AEC9-1D55CB4F4917

P932

Q28657600-34CD74A4-6D13-4DDB-9BA2-DED41DF7E3B0

P3181

P356

J.BIOPSYCH.2011.04.013

P1433

Biological Psychiatry

P1476

Meta-analysis of cytokine alte ...... atus and antipsychotic effects

@en

P2093

Andrew Mellor

http://www.w3.org/2001/XMLSchema#string

Brian J Miller

http://www.w3.org/2001/XMLSchema#string

Peter Buckley

http://www.w3.org/2001/XMLSchema#string

Wesley Seabolt

http://www.w3.org/2001/XMLSchema#string

P2860

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.

Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.

Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia.

P304

663-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1251169

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BIOPSYCH.2011.04.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Brian Kirkpatrick

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51191869

http://www.w3.org/2001/XMLSchema#string

P698

21641581

http://www.w3.org/2001/XMLSchema#string

P921

P932

4071300

http://www.w3.org/2001/XMLSchema#string